Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Related structures:
AlphaFold database: A4HLY2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 110 | 114 | PF00656 | 0.618 |
CLV_NRD_NRD_1 | 107 | 109 | PF00675 | 0.652 |
CLV_NRD_NRD_1 | 59 | 61 | PF00675 | 0.382 |
CLV_PCSK_KEX2_1 | 107 | 109 | PF00082 | 0.527 |
CLV_PCSK_KEX2_1 | 163 | 165 | PF00082 | 0.610 |
CLV_PCSK_KEX2_1 | 74 | 76 | PF00082 | 0.293 |
CLV_PCSK_KEX2_1 | 88 | 90 | PF00082 | 0.214 |
CLV_PCSK_PC1ET2_1 | 74 | 76 | PF00082 | 0.392 |
CLV_PCSK_PC1ET2_1 | 88 | 90 | PF00082 | 0.180 |
CLV_PCSK_SKI1_1 | 45 | 49 | PF00082 | 0.297 |
CLV_PCSK_SKI1_1 | 61 | 65 | PF00082 | 0.388 |
CLV_PCSK_SKI1_1 | 98 | 102 | PF00082 | 0.480 |
DEG_APCC_DBOX_1 | 44 | 52 | PF00400 | 0.297 |
DOC_CYCLIN_RxL_1 | 95 | 105 | PF00134 | 0.555 |
DOC_MAPK_gen_1 | 88 | 96 | PF00069 | 0.389 |
DOC_PP1_RVXF_1 | 59 | 66 | PF00149 | 0.410 |
DOC_USP7_MATH_1 | 155 | 159 | PF00917 | 0.633 |
DOC_WW_Pin1_4 | 6 | 11 | PF00397 | 0.612 |
LIG_FHA_1 | 38 | 44 | PF00498 | 0.357 |
LIG_FHA_1 | 6 | 12 | PF00498 | 0.456 |
LIG_FHA_2 | 108 | 114 | PF00498 | 0.616 |
LIG_LIR_Gen_1 | 120 | 129 | PF02991 | 0.463 |
LIG_LIR_Nem_3 | 120 | 126 | PF02991 | 0.460 |
LIG_LIR_Nem_3 | 29 | 33 | PF02991 | 0.471 |
LIG_NRP_CendR_1 | 163 | 165 | PF00754 | 0.602 |
LIG_PTB_Apo_2 | 29 | 36 | PF02174 | 0.388 |
LIG_PTB_Phospho_1 | 29 | 35 | PF10480 | 0.395 |
LIG_SH2_GRB2like | 140 | 143 | PF00017 | 0.573 |
LIG_SH2_SRC | 140 | 143 | PF00017 | 0.573 |
LIG_SH2_STAP1 | 140 | 144 | PF00017 | 0.653 |
LIG_SH2_STAT3 | 151 | 154 | PF00017 | 0.555 |
LIG_SH2_STAT3 | 35 | 38 | PF00017 | 0.473 |
LIG_SH2_STAT5 | 151 | 154 | PF00017 | 0.596 |
LIG_SH2_STAT5 | 42 | 45 | PF00017 | 0.410 |
LIG_TRAF2_1 | 56 | 59 | PF00917 | 0.201 |
LIG_WRC_WIRS_1 | 27 | 32 | PF05994 | 0.468 |
MOD_GlcNHglycan | 129 | 132 | PF01048 | 0.494 |
MOD_GlcNHglycan | 155 | 158 | PF01048 | 0.663 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.334 |
MOD_GSK3_1 | 140 | 147 | PF00069 | 0.598 |
MOD_GSK3_1 | 155 | 162 | PF00069 | 0.578 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.476 |
MOD_NEK2_2 | 37 | 42 | PF00069 | 0.438 |
MOD_PIKK_1 | 150 | 156 | PF00454 | 0.557 |
MOD_PKA_1 | 107 | 113 | PF00069 | 0.646 |
MOD_PKA_2 | 107 | 113 | PF00069 | 0.646 |
MOD_Plk_1 | 140 | 146 | PF00069 | 0.598 |
MOD_Plk_4 | 37 | 43 | PF00069 | 0.410 |
MOD_ProDKin_1 | 6 | 12 | PF00069 | 0.614 |
MOD_SUMO_rev_2 | 58 | 63 | PF00179 | 0.355 |
TRG_DiLeu_BaEn_1 | 59 | 64 | PF01217 | 0.297 |
TRG_DiLeu_BaLyEn_6 | 7 | 12 | PF01217 | 0.552 |
TRG_ENDOCYTIC_2 | 44 | 47 | PF00928 | 0.313 |
TRG_ER_diArg_1 | 106 | 108 | PF00400 | 0.560 |
TRG_ER_diArg_1 | 163 | 165 | PF00400 | 0.659 |
TRG_ER_diArg_1 | 65 | 68 | PF00400 | 0.298 |
TRG_Pf-PMV_PEXEL_1 | 98 | 102 | PF00026 | 0.529 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1HZD1 | Leptomonas seymouri | 82% | 99% |
A0A0S4JQG9 | Bodo saltans | 47% | 92% |
A0A1X0NRJ6 | Trypanosomatidae | 63% | 100% |
A0A3Q8IU86 | Leishmania donovani | 88% | 99% |
A0A422N9P9 | Trypanosoma rangeli | 64% | 100% |
A4I9B1 | Leishmania infantum | 89% | 99% |
C9ZJB5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 65% | 100% |
E9B4B1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 88% | 100% |
Q4Q3R5 | Leishmania major | 89% | 100% |